APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Weight Loss Pills

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prescription Weight Loss Pills Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchPrescription Weight Loss Pills Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Weight Loss Pills Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Prescription Weight Loss Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Weight Loss Pills Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Weight Loss Pills Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Weight Loss Pills market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prescription Weight Loss Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prescription Weight Loss Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prescription Weight Loss Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prescription Weight Loss Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prescription Weight Loss Pills include Teva Pharmaceutical (Actavis), Sanofi (Adlyxin), Novo Nordisk A/S, Eli Lilly and Company (TRICARE), Pfizer, AstraZeneca (BYDUREON BCise), VIVUS (Qsymia), Rhythm Pharmaceuticals (Imcivree) and Haleon Group (alli), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prescription Weight Loss Pills, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prescription Weight Loss Pills, also provides the sales of main regions and countries. Of the upcoming market potential for Prescription Weight Loss Pills, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prescription Weight Loss Pills sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prescription Weight Loss Pills market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prescription Weight Loss Pills sales, projected growth trends, production technology, application and end-user industry.

Prescription Weight Loss Pills Segment by Company

Teva Pharmaceutical (Actavis)

Sanofi (Adlyxin)

Novo Nordisk A/S

Eli Lilly and Company (TRICARE)

Pfizer

AstraZeneca (BYDUREON BCise)

VIVUS (Qsymia)

Rhythm Pharmaceuticals (Imcivree)

Haleon Group (alli)

Currax Pharmaceuticals (Contrave)

CHEPLAPHARM (Xenical)

Prescription Weight Loss Pills Segment by Type

Injections

Oral Tablets

Oral Capsules

Prescription Weight Loss Pills Segment by Application

Hospital

Pharmacy

Prescription Weight Loss Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Weight Loss Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Weight Loss Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Weight Loss Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prescription Weight Loss Pills in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Weight Loss Pills sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prescription Weight Loss Pills Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injections Major Manufacturers Table 3. Oral Tablets Major Manufacturers Table 4. Oral Capsules Major Manufacturers Table 5. Global Prescription Weight Loss Pills Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Prescription Weight Loss Pills Industry Trends Table 9. Prescription Weight Loss Pills Industry Drivers Table 10. Prescription Weight Loss Pills Industry Opportunities and Challenges Table 11. Prescription Weight Loss Pills Industry Restraints Table 12. Global Prescription Weight Loss Pills Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Prescription Weight Loss Pills Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Prescription Weight Loss Pills Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Prescription Weight Loss Pills Revenue Market Share by Region (2021-2026) Table 16. Global Prescription Weight Loss Pills Revenue Market Share by Region (2027-2032) Table 17. Global Prescription Weight Loss Pills Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Prescription Weight Loss Pills Sales by Region (2021-2026) & (k units) Table 19. Global Prescription Weight Loss Pills Sales by Region (2027-2032) & (k units) Table 20. Global Prescription Weight Loss Pills Sales Market Share by Region (2021-2026) Table 21. Global Prescription Weight Loss Pills Sales Market Share by Region (2027-2032) Table 22. Global Prescription Weight Loss Pills Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Prescription Weight Loss Pills Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Prescription Weight Loss Pills Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2021-2026) Table 26. Global Prescription Weight Loss Pills Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Prescription Weight Loss Pills Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Prescription Weight Loss Pills Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Prescription Weight Loss Pills Manufacturers, Product Type & Application Table 30. Global Prescription Weight Loss Pills Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Prescription Weight Loss Pills by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Prescription Weight Loss Pills Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Prescription Weight Loss Pills Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Prescription Weight Loss Pills Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2026) Table 37. Global Prescription Weight Loss Pills Revenue Market Share by Type (2027-2032) Table 38. Global Prescription Weight Loss Pills Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 40. Global Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 41. Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2026) Table 42. Global Prescription Weight Loss Pills Sales Market Share by Type (2027-2032) Table 43. Global Prescription Weight Loss Pills Price by Type (2021-2026) & (US$/unit) Table 44. Global Prescription Weight Loss Pills Price by Type (2027-2032) & (US$/unit) Table 45. Global Prescription Weight Loss Pills Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Prescription Weight Loss Pills Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Prescription Weight Loss Pills Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2026) Table 49. Global Prescription Weight Loss Pills Revenue Market Share by Application (2027-2032) Table 50. Global Prescription Weight Loss Pills Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 52. Global Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 53. Global Prescription Weight Loss Pills Sales Market Share by Application (2021-2026) Table 54. Global Prescription Weight Loss Pills Sales Market Share by Application (2027-2032) Table 55. Global Prescription Weight Loss Pills Price by Application (2021-2026) & (US$/unit) Table 56. Global Prescription Weight Loss Pills Price by Application (2027-2032) & (US$/unit) Table 57. Teva Pharmaceutical (Actavis) Company Information Table 58. Teva Pharmaceutical (Actavis) Business Overview Table 59. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio Table 61. Teva Pharmaceutical (Actavis) Recent Development Table 62. Sanofi (Adlyxin) Company Information Table 63. Sanofi (Adlyxin) Business Overview Table 64. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio Table 66. Sanofi (Adlyxin) Recent Development Table 67. Novo Nordisk A/S Company Information Table 68. Novo Nordisk A/S Business Overview Table 69. Novo Nordisk A/S Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio Table 71. Novo Nordisk A/S Recent Development Table 72. Eli Lilly and Company (TRICARE) Company Information Table 73. Eli Lilly and Company (TRICARE) Business Overview Table 74. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio Table 76. Eli Lilly and Company (TRICARE) Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Pfizer Prescription Weight Loss Pills Product Portfolio Table 81. Pfizer Recent Development Table 82. AstraZeneca (BYDUREON BCise) Company Information Table 83. AstraZeneca (BYDUREON BCise) Business Overview Table 84. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio Table 86. AstraZeneca (BYDUREON BCise) Recent Development Table 87. VIVUS (Qsymia) Company Information Table 88. VIVUS (Qsymia) Business Overview Table 89. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio Table 91. VIVUS (Qsymia) Recent Development Table 92. Rhythm Pharmaceuticals (Imcivree) Company Information Table 93. Rhythm Pharmaceuticals (Imcivree) Business Overview Table 94. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio Table 96. Rhythm Pharmaceuticals (Imcivree) Recent Development Table 97. Haleon Group (alli) Company Information Table 98. Haleon Group (alli) Business Overview Table 99. Haleon Group (alli) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio Table 101. Haleon Group (alli) Recent Development Table 102. Currax Pharmaceuticals (Contrave) Company Information Table 103. Currax Pharmaceuticals (Contrave) Business Overview Table 104. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio Table 106. Currax Pharmaceuticals (Contrave) Recent Development Table 107. CHEPLAPHARM (Xenical) Company Information Table 108. CHEPLAPHARM (Xenical) Business Overview Table 109. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio Table 111. CHEPLAPHARM (Xenical) Recent Development Table 112. North America Prescription Weight Loss Pills Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Prescription Weight Loss Pills Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 115. North America Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 116. North America Prescription Weight Loss Pills Sales Price by Type (2021-2026) & (US$/unit) Table 117. North America Prescription Weight Loss Pills Sales Price by Type (2027-2032) & (US$/unit) Table 118. North America Prescription Weight Loss Pills Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Prescription Weight Loss Pills Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 121. North America Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 122. North America Prescription Weight Loss Pills Sales Price by Application (2021-2026) & (US$/unit) Table 123. North America Prescription Weight Loss Pills Sales Price by Application (2027-2032) & (US$/unit) Table 124. North America Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Prescription Weight Loss Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Prescription Weight Loss Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 128. North America Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 129. North America Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 130. North America Prescription Weight Loss Pills Sales Price by Country (2021-2026) & (US$/unit) Table 131. North America Prescription Weight Loss Pills Sales Price by Country (2027-2032) & (US$/unit) Table 132. United States Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 133. Canada Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 134. Mexico Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 135. Europe Prescription Weight Loss Pills Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Prescription Weight Loss Pills Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 138. Europe Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 139. Europe Prescription Weight Loss Pills Sales Price by Type (2021-2026) & (US$/unit) Table 140. Europe Prescription Weight Loss Pills Sales Price by Type (2027-2032) & (US$/unit) Table 141. Europe Prescription Weight Loss Pills Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Prescription Weight Loss Pills Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 144. Europe Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 145. Europe Prescription Weight Loss Pills Sales Price by Application (2021-2026) & (US$/unit) Table 146. Europe Prescription Weight Loss Pills Sales Price by Application (2027-2032) & (US$/unit) Table 147. Europe Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Prescription Weight Loss Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Prescription Weight Loss Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 151. Europe Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 152. Europe Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 153. Europe Prescription Weight Loss Pills Sales Price by Country (2021-2026) & (US$/unit) Table 154. Europe Prescription Weight Loss Pills Sales Price by Country (2027-2032) & (US$/unit) Table 155. Germany Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 156. France Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 157. U.K. Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 158. Italy Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 159. Russia Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 160. Spain Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 163. Sweden Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 164. Poland Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 165. China Prescription Weight Loss Pills Revenue by Type (2021-2026) & (US$ Million) Table 166. China Prescription Weight Loss Pills Revenue by Type (2027-2032) & (US$ Million) Table 167. China Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 168. China Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 169. China Prescription Weight Loss Pills Sales Price by Type (2021-2026) & (US$/unit) Table 170. China Prescription Weight Loss Pills Sales Price by Type (2027-2032) & (US$/unit) Table 171. China Prescription Weight Loss Pills Revenue by Application (2021-2026) & (US$ Million) Table 172. China Prescription Weight Loss Pills Revenue by Application (2027-2032) & (US$ Million) Table 173. China Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 174. China Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 175. China Prescription Weight Loss Pills Sales Price by Application (2021-2026) & (US$/unit) Table 176. China Prescription Weight Loss Pills Sales Price by Application (2027-2032) & (US$/unit) Table 177. Asia Prescription Weight Loss Pills Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Prescription Weight Loss Pills Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 180. Asia Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 181. Asia Prescription Weight Loss Pills Sales Price by Type (2021-2026) & (US$/unit) Table 182. Asia Prescription Weight Loss Pills Sales Price by Type (2027-2032) & (US$/unit) Table 183. Asia Prescription Weight Loss Pills Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Prescription Weight Loss Pills Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 186. Asia Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 187. Asia Prescription Weight Loss Pills Sales Price by Application (2021-2026) & (US$/unit) Table 188. Asia Prescription Weight Loss Pills Sales Price by Application (2027-2032) & (US$/unit) Table 189. Asia Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Prescription Weight Loss Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Prescription Weight Loss Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 193. Asia Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 194. Asia Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 195. Asia Prescription Weight Loss Pills Sales Price by Country (2021-2026) & (US$/unit) Table 196. Asia Prescription Weight Loss Pills Sales Price by Country (2027-2032) & (US$/unit) Table 197. Japan Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 198. South Korea Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 199. India Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 200. Australia Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Prescription Weight Loss Pills Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Prescription Weight Loss Pills Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 206. SAMEA Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 207. SAMEA Prescription Weight Loss Pills Sales Price by Type (2021-2026) & (US$/unit) Table 208. SAMEA Prescription Weight Loss Pills Sales Price by Type (2027-2032) & (US$/unit) Table 209. SAMEA Prescription Weight Loss Pills Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Prescription Weight Loss Pills Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 212. SAMEA Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 213. SAMEA Prescription Weight Loss Pills Sales Price by Application (2021-2026) & (US$/unit) Table 214. SAMEA Prescription Weight Loss Pills Sales Price by Application (2027-2032) & (US$/unit) Table 215. SAMEA Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Prescription Weight Loss Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Prescription Weight Loss Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. SAMEA Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 220. SAMEA Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 221. SAMEA Prescription Weight Loss Pills Sales Price by Country (2021-2026) & (US$/unit) Table 222. SAMEA Prescription Weight Loss Pills Sales Price by Country (2027-2032) & (US$/unit) Table 223. Brazil Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 224. Argentina Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 225. Chile Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 226. Colombia Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 227. Peru Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 229. Israel Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 230. UAE Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 231. Turkey Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 232. Iran Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 233. Egypt Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Prescription Weight Loss Pills Distributors List Table 237. Prescription Weight Loss Pills Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Prescription Weight Loss Pills Image Figure 2. Global Prescription Weight Loss Pills Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Weight Loss Pills Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injections Image Figure 5. Oral Tablets Image Figure 6. Oral Capsules Image Figure 7. Global Prescription Weight Loss Pills Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Prescription Weight Loss Pills Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Pharmacy Image Figure 11. Global Prescription Weight Loss Pills Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Figure 13. Global Prescription Weight Loss Pills Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Prescription Weight Loss Pills Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Prescription Weight Loss Pills Revenue Market Share by Region (2021-2032) Figure 16. Global Prescription Weight Loss Pills Sales (2021-2032) & (k units) Figure 17. Global Prescription Weight Loss Pills Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Prescription Weight Loss Pills Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Prescription Weight Loss Pills Sales YoY (2021-2032) & (k units) Figure 20. Europe Prescription Weight Loss Pills Sales YoY (2021-2032) & (k units) Figure 21. China Prescription Weight Loss Pills Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Prescription Weight Loss Pills Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Prescription Weight Loss Pills Sales YoY (2021-2032) & (k units) Figure 24. Global Prescription Weight Loss Pills Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Prescription Weight Loss Pills Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Prescription Weight Loss Pills Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Prescription Weight Loss Pills Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2032) Figure 30. Global Prescription Weight Loss Pills Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Prescription Weight Loss Pills Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2032) Figure 33. Global Prescription Weight Loss Pills Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Prescription Weight Loss Pills Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2032) Figure 36. Global Prescription Weight Loss Pills Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Prescription Weight Loss Pills Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Prescription Weight Loss Pills Sales Market Share by Application (2021-2032) Figure 39. North America Prescription Weight Loss Pills Revenue Share by Type (2021-2032) Figure 40. North America Prescription Weight Loss Pills Sales Share by Type (2021-2032) Figure 41. North America Prescription Weight Loss Pills Revenue Share by Application (2021-2032) Figure 42. North America Prescription Weight Loss Pills Sales Share by Application (2021-2032) Figure 43. North America Prescription Weight Loss Pills Revenue Share by Country (2021-2032) Figure 44. North America Prescription Weight Loss Pills Sales Share by Country (2021-2032) Figure 45. Europe Prescription Weight Loss Pills Revenue Share by Type (2021-2032) Figure 46. Europe Prescription Weight Loss Pills Sales Share by Type (2021-2032) Figure 47. Europe Prescription Weight Loss Pills Revenue Share by Application (2021-2032) Figure 48. Europe Prescription Weight Loss Pills Sales Share by Application (2021-2032) Figure 49. Europe Prescription Weight Loss Pills Revenue Share by Country (2021-2032) Figure 50. Europe Prescription Weight Loss Pills Sales Share by Country (2021-2032) Figure 51. China Prescription Weight Loss Pills Revenue Share by Type (2021-2032) Figure 52. China Prescription Weight Loss Pills Sales Share by Type (2021-2032) Figure 53. China Prescription Weight Loss Pills Revenue Share by Application (2021-2032) Figure 54. China Prescription Weight Loss Pills Sales Share by Application (2021-2032) Figure 55. Asia Prescription Weight Loss Pills Revenue Share by Type (2021-2032) Figure 56. Asia Prescription Weight Loss Pills Sales Share by Type (2021-2032) Figure 57. Asia Prescription Weight Loss Pills Revenue Share by Application (2021-2032) Figure 58. Asia Prescription Weight Loss Pills Sales Share by Application (2021-2032) Figure 59. Asia Prescription Weight Loss Pills Revenue Share by Country (2021-2032) Figure 60. Asia Prescription Weight Loss Pills Sales Share by Country (2021-2032) Figure 61. SAMEA Prescription Weight Loss Pills Revenue Share by Type (2021-2032) Figure 62. SAMEA Prescription Weight Loss Pills Sales Share by Type (2021-2032) Figure 63. SAMEA Prescription Weight Loss Pills Revenue Share by Application (2021-2032) Figure 64. SAMEA Prescription Weight Loss Pills Sales Share by Application (2021-2032) Figure 65. SAMEA Prescription Weight Loss Pills Revenue Share by Country (2021-2032) Figure 66. SAMEA Prescription Weight Loss Pills Sales Share by Country (2021-2032) Figure 67. Prescription Weight Loss Pills Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prescription Weight Loss Pills Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Oral Tablets
  • Oral Capsules
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Teva Pharmaceutical (Actavis)
  • Sanofi (Adlyxin)
  • Novo Nordisk A/S
  • Eli Lilly and Company (TRICARE)
  • Pfizer
  • AstraZeneca (BYDUREON BCise)
  • VIVUS (Qsymia)
  • Rhythm Pharmaceuticals (Imcivree)
  • Haleon Group (alli)
  • Currax Pharmaceuticals (Contrave)
  • CHEPLAPHARM (Xenical)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prescription Weight Loss Pills Market by Type
  3. 1.2.1 Global Prescription Weight Loss Pills Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injections
  5. 1.2.3 Oral Tablets
  6. 1.2.4 Oral Capsules
  7. 1.3 Prescription Weight Loss Pills Market by Application
  8. 1.3.1 Global Prescription Weight Loss Pills Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Prescription Weight Loss Pills Market Dynamics
  1. 2.1 Prescription Weight Loss Pills Industry Trends
  2. 2.2 Prescription Weight Loss Pills Industry Drivers
  3. 2.3 Prescription Weight Loss Pills Industry Opportunities and Challenges
  4. 2.4 Prescription Weight Loss Pills Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prescription Weight Loss Pills Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prescription Weight Loss Pills Revenue by Region
  3. 3.2.1 Global Prescription Weight Loss Pills Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prescription Weight Loss Pills Revenue by Region (2021-2026)
  5. 3.2.3 Global Prescription Weight Loss Pills Revenue by Region (2027-2032)
  6. 3.2.4 Global Prescription Weight Loss Pills Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prescription Weight Loss Pills Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prescription Weight Loss Pills Sales by Region
  9. 3.4.1 Global Prescription Weight Loss Pills Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prescription Weight Loss Pills Sales by Region (2021-2026)
  11. 3.4.3 Global Prescription Weight Loss Pills Sales by Region (2027-2032)
  12. 3.4.4 Global Prescription Weight Loss Pills Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prescription Weight Loss Pills Revenue by Manufacturers
  2. 4.1.1 Global Prescription Weight Loss Pills Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prescription Weight Loss Pills Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prescription Weight Loss Pills Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prescription Weight Loss Pills Sales by Manufacturers
  6. 4.2.1 Global Prescription Weight Loss Pills Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prescription Weight Loss Pills Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prescription Weight Loss Pills Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prescription Weight Loss Pills Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prescription Weight Loss Pills Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prescription Weight Loss Pills Manufacturers, Product Type & Application
  13. 4.7 Global Prescription Weight Loss Pills Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prescription Weight Loss Pills Market CR5 and HHI
  16. 4.8.2 2025 Prescription Weight Loss Pills Tier 1, Tier 2, and Tier 3
5 Prescription Weight Loss Pills Market by Type
  1. 5.1 Global Prescription Weight Loss Pills Revenue by Type
  2. 5.1.1 Global Prescription Weight Loss Pills Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prescription Weight Loss Pills Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prescription Weight Loss Pills Sales by Type
  6. 5.2.1 Global Prescription Weight Loss Pills Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prescription Weight Loss Pills Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prescription Weight Loss Pills Price by Type
6 Prescription Weight Loss Pills Market by Application
  1. 6.1 Global Prescription Weight Loss Pills Revenue by Application
  2. 6.1.1 Global Prescription Weight Loss Pills Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prescription Weight Loss Pills Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prescription Weight Loss Pills Sales by Application
  6. 6.2.1 Global Prescription Weight Loss Pills Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prescription Weight Loss Pills Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Prescription Weight Loss Pills Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prescription Weight Loss Pills Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical (Actavis)
  2. 7.1.1 Teva Pharmaceutical (Actavis) Company Information
  3. 7.1.2 Teva Pharmaceutical (Actavis) Business Overview
  4. 7.1.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
  6. 7.1.5 Teva Pharmaceutical (Actavis) Recent Developments
  7. 7.2 Sanofi (Adlyxin)
  8. 7.2.1 Sanofi (Adlyxin) Company Information
  9. 7.2.2 Sanofi (Adlyxin) Business Overview
  10. 7.2.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
  12. 7.2.5 Sanofi (Adlyxin) Recent Developments
  13. 7.3 Novo Nordisk A/S
  14. 7.3.1 Novo Nordisk A/S Company Information
  15. 7.3.2 Novo Nordisk A/S Business Overview
  16. 7.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
  18. 7.3.5 Novo Nordisk A/S Recent Developments
  19. 7.4 Eli Lilly and Company (TRICARE)
  20. 7.4.1 Eli Lilly and Company (TRICARE) Company Information
  21. 7.4.2 Eli Lilly and Company (TRICARE) Business Overview
  22. 7.4.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
  24. 7.4.5 Eli Lilly and Company (TRICARE) Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Prescription Weight Loss Pills Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 AstraZeneca (BYDUREON BCise)
  32. 7.6.1 AstraZeneca (BYDUREON BCise) Company Information
  33. 7.6.2 AstraZeneca (BYDUREON BCise) Business Overview
  34. 7.6.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
  36. 7.6.5 AstraZeneca (BYDUREON BCise) Recent Developments
  37. 7.7 VIVUS (Qsymia)
  38. 7.7.1 VIVUS (Qsymia) Company Information
  39. 7.7.2 VIVUS (Qsymia) Business Overview
  40. 7.7.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
  42. 7.7.5 VIVUS (Qsymia) Recent Developments
  43. 7.8 Rhythm Pharmaceuticals (Imcivree)
  44. 7.8.1 Rhythm Pharmaceuticals (Imcivree) Company Information
  45. 7.8.2 Rhythm Pharmaceuticals (Imcivree) Business Overview
  46. 7.8.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
  48. 7.8.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments
  49. 7.9 Haleon Group (alli)
  50. 7.9.1 Haleon Group (alli) Company Information
  51. 7.9.2 Haleon Group (alli) Business Overview
  52. 7.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
  54. 7.9.5 Haleon Group (alli) Recent Developments
  55. 7.10 Currax Pharmaceuticals (Contrave)
  56. 7.10.1 Currax Pharmaceuticals (Contrave) Company Information
  57. 7.10.2 Currax Pharmaceuticals (Contrave) Business Overview
  58. 7.10.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
  60. 7.10.5 Currax Pharmaceuticals (Contrave) Recent Developments
  61. 7.11 CHEPLAPHARM (Xenical)
  62. 7.11.1 CHEPLAPHARM (Xenical) Company Information
  63. 7.11.2 CHEPLAPHARM (Xenical) Business Overview
  64. 7.11.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
  66. 7.11.5 CHEPLAPHARM (Xenical) Recent Developments
8 North America
  1. 8.1 North America Prescription Weight Loss Pills Market Size by Type
  2. 8.1.1 North America Prescription Weight Loss Pills Revenue by Type (2021-2032)
  3. 8.1.2 North America Prescription Weight Loss Pills Sales by Type (2021-2032)
  4. 8.1.3 North America Prescription Weight Loss Pills Price by Type (2021-2032)
  5. 8.2 North America Prescription Weight Loss Pills Market Size by Application
  6. 8.2.1 North America Prescription Weight Loss Pills Revenue by Application (2021-2032)
  7. 8.2.2 North America Prescription Weight Loss Pills Sales by Application (2021-2032)
  8. 8.2.3 North America Prescription Weight Loss Pills Price by Application (2021-2032)
  9. 8.3 North America Prescription Weight Loss Pills Market Size by Country
  10. 8.3.1 North America Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prescription Weight Loss Pills Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Prescription Weight Loss Pills Market Size by Type
  2. 9.1.1 Europe Prescription Weight Loss Pills Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prescription Weight Loss Pills Sales by Type (2021-2032)
  4. 9.1.3 Europe Prescription Weight Loss Pills Price by Type (2021-2032)
  5. 9.2 Europe Prescription Weight Loss Pills Market Size by Application
  6. 9.2.1 Europe Prescription Weight Loss Pills Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prescription Weight Loss Pills Sales by Application (2021-2032)
  8. 9.2.3 Europe Prescription Weight Loss Pills Price by Application (2021-2032)
  9. 9.3 Europe Prescription Weight Loss Pills Market Size by Country
  10. 9.3.1 Europe Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prescription Weight Loss Pills Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Prescription Weight Loss Pills Market Size by Type
  2. 10.1.1 China Prescription Weight Loss Pills Revenue by Type (2021-2032)
  3. 10.1.2 China Prescription Weight Loss Pills Sales by Type (2021-2032)
  4. 10.1.3 China Prescription Weight Loss Pills Price by Type (2021-2032)
  5. 10.2 China Prescription Weight Loss Pills Market Size by Application
  6. 10.2.1 China Prescription Weight Loss Pills Revenue by Application (2021-2032)
  7. 10.2.2 China Prescription Weight Loss Pills Sales by Application (2021-2032)
  8. 10.2.3 China Prescription Weight Loss Pills Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prescription Weight Loss Pills Market Size by Type
  2. 11.1.1 Asia Prescription Weight Loss Pills Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prescription Weight Loss Pills Sales by Type (2021-2032)
  4. 11.1.3 Asia Prescription Weight Loss Pills Price by Type (2021-2032)
  5. 11.2 Asia Prescription Weight Loss Pills Market Size by Application
  6. 11.2.1 Asia Prescription Weight Loss Pills Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prescription Weight Loss Pills Sales by Application (2021-2032)
  8. 11.2.3 Asia Prescription Weight Loss Pills Price by Application (2021-2032)
  9. 11.3 Asia Prescription Weight Loss Pills Market Size by Country
  10. 11.3.1 Asia Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prescription Weight Loss Pills Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prescription Weight Loss Pills Market Size by Type
  2. 12.1.1 SAMEA Prescription Weight Loss Pills Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prescription Weight Loss Pills Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prescription Weight Loss Pills Price by Type (2021-2032)
  5. 12.2 SAMEA Prescription Weight Loss Pills Market Size by Application
  6. 12.2.1 SAMEA Prescription Weight Loss Pills Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prescription Weight Loss Pills Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prescription Weight Loss Pills Price by Application (2021-2032)
  9. 12.3 SAMEA Prescription Weight Loss Pills Market Size by Country
  10. 12.3.1 SAMEA Prescription Weight Loss Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prescription Weight Loss Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prescription Weight Loss Pills Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prescription Weight Loss Pills Value Chain Analysis
  2. 13.1.1 Prescription Weight Loss Pills Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prescription Weight Loss Pills Production Mode & Process
  6. 13.2 Prescription Weight Loss Pills Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prescription Weight Loss Pills Distributors
  9. 13.2.3 Prescription Weight Loss Pills Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst